Our Experiences With Erlotinib in Second and Third Line Treatment Patients With Advanced Stage Iiib Iv Non-Small Cell Lung Cancer. Biomol Biomed 2008, 8 (4), 386-390. https://doi.org/10.17305/bjbms.2008.2905.